Alx Oncology Holdings (ALXO) Non Operating Income (2020 - 2022)
Alx Oncology Holdings (ALXO) reported Non Operating Income of $1.8 million for Q4 2022, up 8504.76% on a YoY basis from $21000.0 in Q4 2021, and up 31.9% sequentially from $1.4 million in Q3 2022.
Alx Oncology Holdings (ALXO) Non Operating Income (2020 - 2022) Analysis & Trends
Alx Oncology Holdings (ALXO) has 3 years of Non Operating Income data on file, last reported at $1.8 million in Q4 2022.
- For the quarter ending Q4 2022, Non Operating Income rose 8504.76% year-over-year to $1.8 million; the trailing twelve-month figure through Dec 2022 stood at $4.3 million (up 4601.1% YoY), and the FY2022 full-year result was $4.3 million, up 4601.1% from the prior year.
- Non Operating Income grew to $1.8 million in Q4 2022, from $1.4 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.8 million in Q4 2022 to a low of -$226000.0 in Q3 2020.
- A 3-year average of $374416.7 and a median of $24000.0 in 2021 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income slumped 97.32% in 2021 and jumped 8504.76% in 2022, its largest moves.
- Tracing ALXO's Non Operating Income over 3 years: stood at $784000.0 in 2020, then tumbled by 97.32% to $21000.0 in 2021, then jumped by 8504.76% to $1.8 million in 2022.
- Business Quant data shows ALXO's Non Operating Income at $1.8 million in Q4 2022, $1.4 million in Q3 2022, and $876000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Alx Oncology Holdings | 211.24 Mn | 211.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.81 Mn |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 876,000.00 |
| Mar 31, 2022 | 225,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Jun 30, 2021 | 23,000.00 |
| Mar 31, 2021 | 25,000.00 |
| Dec 31, 2020 | 784,000.00 |
| Sep 30, 2020 | -226,000.00 |
| Jun 30, 2020 | -219,000.00 |
| Mar 31, 2020 | -215,000.00 |